Ets proteins in biological control and cancer

被引:235
作者
Hsu, T
Trojanowska, M
Watson, DK
机构
[1] Med Univ S Carolina, Hollings Canc Ctr, Dept Pathol & Lab Med, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA
关键词
Ets; transcriptional regulation; ECM; cancer; invasion; metastasis; EMT; epithelium; stroma;
D O I
10.1002/jcb.20012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Ets family consists of a large number of evolutionarily conserved transcription factors, many of which have been implicated in tumor progression. Extensive studies on this family of proteins have focused so far mainly on the biochemical properties and cellular functions of individual factors. Since most of the Ets factors can bind to the core consensus DNA sequence GGAA/T in vitro, it has been a challenge to differentiate redundant from specific functions of various Ets proteins in vivo. Recent findings, however, suggest that such apparent redundancy may in fact be a central component of a network of differentially regulated specific Ets factors, resulting in distinct biological and pathological consequences. The programmed "Ets conversion" appears to play a critical role during tumor progression, especially in control of cellular changes during epithelial-mesenchymal transition and metastasis. Coordination of multiple Ets gene functions also mediates interactions between tumor and stromal cells. As such, these new insights may provide a novel view of the Ets gene family as well as a focal point for studying the complex biological control involved in tumor progression. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:896 / 903
页数:8
相关论文
共 35 条
[11]   Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu [J].
Goel, A ;
Janknecht, R .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (17) :6243-6254
[12]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[13]   Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia [J].
Hart, A ;
Melet, F ;
Grossfeld, P ;
Chien, K ;
Jones, C ;
Tunnacliffe, A ;
Favier, R ;
Bernstein, A .
IMMUNITY, 2000, 13 (02) :167-177
[14]   FGF5 AS A REGULATOR OF THE HAIR-GROWTH CYCLE - EVIDENCE FROM TARGETED AND SPONTANEOUS MUTATIONS [J].
HEBERT, JM ;
ROSENQUIST, T ;
GOTZ, J ;
MARTIN, GR .
CELL, 1994, 78 (06) :1017-1025
[15]  
JINNIN M, IN PRESS ONCOGENE
[16]   A multigenic program mediating breast cancer metastasis to bone [J].
Kang, YB ;
Siegel, PM ;
Shu, WP ;
Drobnjak, M ;
Kakonen, SM ;
Cordón-Cardo, C ;
Guise, TA ;
Massagué, J .
CANCER CELL, 2003, 3 (06) :537-549
[17]   Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice [J].
Kawada, H ;
Ito, T ;
Pharr, PN ;
Spyropoulos, DD ;
Watson, DK ;
Ogawa, M .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (04) :463-468
[18]   An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation [J].
Klappacher, GW ;
Lunyak, VV ;
Sykes, DB ;
Sawka-Verhelle, D ;
Sage, J ;
Brard, G ;
Ngo, SD ;
Gangadharan, D ;
Jacks, T ;
Kamps, MP ;
Rose, DW ;
Rosenfeld, MG ;
Glass, CK .
CELL, 2002, 109 (02) :169-180
[19]   Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin [J].
Kubo, M ;
Czuwara-Ladykowska, J ;
Moussa, O ;
Markiewicz, M ;
Smith, E ;
Silver, RM ;
Jablonska, S ;
Blaszczyk, M ;
Watson, DK ;
Trojanowska, M .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (02) :571-581
[20]   Coordinated functions of Akt/PKB and ETS1 in tubule formation [J].
Lavenburg, KR ;
Ivey, J ;
Hsu, T ;
Muise-Helmericks, RC .
FASEB JOURNAL, 2003, 17 (13) :2278-+